XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating activities    
Net income $ 77.4 $ 61.0
Non-cash pre-tax expense:    
Depreciation 23.7 24.3
Amortization 8.1 6.5
Stock-based compensation 9.5 7.4
Recognition of actuarial losses   0.9
Deferred income taxes 7.6 (25.1)
Asset impairment charges 3.2  
Amortization of deferred financing fees 0.5 0.4
Changes in assets and liabilities:    
Increase in accounts receivable (12.3) (20.5)
Increase in inventories (26.2) (40.5)
(Decrease) increase in accounts payable (10.6) 31.9
(Increase) decrease in other assets (5.9) 16.8
Decrease in accrued expenses and other liabilities (95.1) (83.7)
Increase in accrued taxes 2.2 14.5
Net cash used in operating activities (17.9) (6.1)
Investing activities    
Capital expenditures [1],[2] (29.5) (43.8)
Cost of acquisition, net of cash acquired (0.1)  
Net cash used in investing activities (29.6) (43.8)
Financing activities    
Increase in short-term debt, net   2.0
Issuance of long-term debt 110.0 510.0
Repayment of long-term debt (50.0) (60.9)
Proceeds from the exercise of stock options 8.7 4.9
Treasury stock purchases (27.3) (362.7)
Employee withholding taxes related to stock-based compensation (7.8) (8.5)
Dividends to stockholders (27.6) (24.4)
Other financing, net   (1.2)
Net cash provided by financing activities 6.0 59.2
Effect of foreign exchange rate changes on cash 0.8 5.8
Net (decrease) increase in cash and cash equivalents (40.7) 15.1
Cash and cash equivalents at beginning of period 251.5 238.5
Cash and cash equivalents at end of period $ 210.8 $ 253.6
[1] Capital expenditures of $7.9 million and $8.7 million that have not been paid as of March 31, 2017 and 2016 respectively, were excluded from the Statement of Cash Flows.
[2] Selling, general and administrative expenses 288.6 270.2